Study of subcutaneous (SC) belimumab in pediatric participants with systemic lupus erythematosus (SLE)

Trial Identifier: 200908
Sponsor: GlaxoSmithKline
Start Date: November 2019
Primary Completion Date: January 2023
Study Completion Date: April 2027
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Argentina Rosario, Argentina, 2000
Germany Berlin, Germany, 13353
Germany St Augustin, Germany, 53757
Japan Kagoshima, Japan, 890-8520
Japan Kanagawa, Japan, 216-8511
Mexico San Luis PotosI, Mexico, 78213
Netherlands ROTTERDAM, Netherlands, 3015 GJ
Spain Barcelona, Spain, 08950
Spain Madrid, Spain, 28034
Spain Valencia, Spain, 46026
United States, OH Cincinatti, OH, United States, 45229